Rare Presentation of Concomitant Alopecia Areata and Vitiligo in a Teenager
May 2021
in “
Skin
”
![Image of study](/images/research/080b5440-3256-4c63-ba6b-0d1ebc2c9074/medium/31482.jpg)
TLDR A teenager had both alopecia areata and vitiligo, which are rare to occur together.
A 13-year-old Caucasian female presented with alopecia areata (AA) and later developed vitiligo, a rare co-occurrence of these autoimmune skin diseases. Initially treated with topical mometasone and prednisolone, she showed new hair depigmentation at a 3-month follow-up, leading to a diagnosis of concomitant vitiligo and the addition of topical tofacitinib. This case highlighted a potential pathogenic link between AA and vitiligo, involving CD8+ cytotoxic T-cells, interferon gamma (IFN-ɣ), and IFN-ɣ-induced chemokines. The co-localization of these conditions posed therapeutic challenges and significant psychological distress for the patient.
View this study on jofskin.org →
Cited in this study
3 / results![Understanding Autoimmunity of Vitiligo and Alopecia Areata](/images/research/2116f06c-fa0a-40a2-ae08-89803d74cf8d/small/31563.jpg)
research Understanding Autoimmunity of Vitiligo and Alopecia Areata
Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.
![Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata](/images/research/0283a96d-bfde-4f13-ae2d-ad160ac53b92/small/31571.jpg)
research Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata
A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.
![Epidemiology and Burden of Alopecia Areata: A Systematic Review](/images/research/a23ca4be-4f59-4223-8d41-47bd72e2d8c4/small/18635.jpg)
research Epidemiology and Burden of Alopecia Areata: A Systematic Review
Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.
Related
4 / results![Alopecia Areata: A Multifactorial Autoimmune Condition](/images/research/69831f24-00f5-4084-b0c4-3c45f87247c8/small/31506.jpg)
research Alopecia Areata: A Multifactorial Autoimmune Condition
Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.
![Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata](/images/research/d3c9ab15-8bb2-48a6-8e00-015335a41a24/small/30080.jpg)
research Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata
A new mix of anthralin and calcipotriene might help treat severe hair loss.
![Linear Alopecia Areata](/images/research/9088ffd0-833b-4e17-ac41-1eee5d80661a/small/32103.jpg)
research Linear Alopecia Areata
Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.
research Treating Resistant Cases of Alopecia Universalis
Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.